Skip to content
  • Sunday, 26 July 2026
  • 1:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Buck Institute Study Reveals How APOE2 Gene Protects Against Alzheimer’s and Promotes Longevity through DNA Repair and Senescence Resistance
Neuroscience & Brain Research

Buck Institute Study Reveals How APOE2 Gene Protects Against Alzheimer’s and Promotes Longevity through DNA Repair and Senescence Resistance

Rifan Muazin Jul 24, 2026 0

For decades, the genetic landscape of Alzheimer’s disease has been dominated by the study of the apolipoprotein E (APOE) gene.…

Read More
Biotech & Genetic Research

Widely Used Weedkiller Glyphosate Implicated in Accelerating Global Antibiotic Resistance Crisis, New Research Reveals.

Jia Lissa Jul 10, 2026 0

A groundbreaking study has unveiled a startling connection between glyphosate, the world’s most ubiquitous weedkiller, and the proliferation of dangerous…

Read More
Biotech & Genetic Research

Weedkiller Glyphosate May Be Fueling the Global Antimicrobial Resistance Crisis, New Research Suggests.

Jia Lissa Jul 3, 2026 0

A groundbreaking study has unveiled a concerning potential link between glyphosate, the world’s most widely used herbicide, and the escalating…

Read More
Biotech & Genetic Research

Wine’s Leftovers Offer a Sustainable Pathway to Wean Chicken Farms Off Antibiotics, Addressing the Antimicrobial Resistance Crisis

Jia Lissa Jun 4, 2026 0

In a significant stride towards sustainable agriculture and public health, new research from Cornell University suggests that the humble by-product…

Read More
Biotech & Genetic Research

A new class of compounds shows promising antibacterial properties, with the potential to aid the fight against antimicrobial resistance.

Jia Lissa May 22, 2026 0

In a significant development in the global battle against antimicrobial resistance (AMR), an international research collaboration spearheaded by scientists at…

Read More
Clinical Diagnostics & Pathology

Doherty Institute Researchers Unveil Groundbreaking Assay Identifying Four STIs and Antibiotic Resistance with Unprecedented Speed and Precision

Reynand Amr Wu Apr 17, 2026 0

Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have announced a significant breakthrough in diagnostic medicine,…

Read More
Clinical Diagnostics & Pathology

Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.

Reynand Amr Wu Apr 10, 2026 0

Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…

Read More
Pharmaceutical R&D

US Government Invests Heavily in Antibiotic Manufacturing to Combat Antimicrobial Resistance

Teuku Ryan Apr 10, 2026 0

The United States government, through the Biomedical Advanced Research and Development Authority (BARDA), has committed up to $482 million to…

Read More
Clinical Diagnostics & Pathology

Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.

Reynand Amr Wu Apr 1, 2026 0

Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…

Read More
Clinical Diagnostics & Pathology

Doherty Institute Researchers Unveil Groundbreaking Assay for Rapid, Precise Detection of Four STIs and Antibiotic Resistance

Reynand Amr Wu Mar 25, 2026 0

Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have developed a portable, point-of-care diagnostic tool capable…

Read More

Posts pagination

1 2
TWiV 1289: Building a better hepatitis B trapThe enemy of your parasite is your friendTWiV 1289: Building a better hepatitis B trapRice University Researchers Develop First Comprehensive Label-Free Molecular Atlas of the Alzheimer’s Brain
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ